1029623-73-1

Usage

General Description

2,5-difluorobenzimidohydrazide is a chemical compound with the molecular formula C7H5F2N3. It is a hydrazide derivative with two fluorine atoms attached to the benzene ring. 2,5-difluorobenzimidohydrazide is used in the synthesis of pharmaceuticals and agrochemicals due to its potential as a building block for various bioactive molecules. It has been studied for its anti-tuberculosis and anti-cancer properties, making it a promising candidate for drug development. Additionally, 2,5-difluorobenzimidohydrazide has potential applications in material science as a precursor for the synthesis of functionalized polymers and other advanced materials. Overall, 2,5-difluorobenzimidohydrazide has shown potential for various industrial and medical applications, making it an important chemical in research and development.

Upstream product

• 64248-64-2 2,5-difluorobenzonitrile 
• 1029623-72-0 2,5-difluorobenzenecarbothioamide 

Downstream Products

• 1029623-74-2 (R)-tert-butyl 1-(2-((2,5-difluorophenyl)(imino)methyl)hydrazinyl)-3,3-dimethyl-1-oxobutan-2-ylcarbamate 
• 1338780-19-0 (R)-tert-butyl (1-(2-((2,5-difluorophenyl)(imino)methyl)hydrazinyl)-3-methoxy-3-methyl-1-oxobutan-2-yl)carbamate 
• 1338780-16-7 (3R,4R)-benzyl 3-(((S)-N-((R)-1-(3-(2,5-difluorophenyl)-1-(3-fluorobenzyl)-1H-1,2,4-triazol-5-yl)-2,2-dimethylpropyl)tetrahydrofuran-2-carboxamido)methyl)-4-fluoropyrrolidine-1-carboxylate 
• 1356965-37-1 C₃₀H₃₆F₃N₅O₃ 
• 1338780-13-4 (3S,4R)-benzyl 3-((((R)-1-(1-(3-fluorobenzyl)-3-(2,5-difluorophenyl)-1H-1,2,4-triazol-5-yl)-2,2-dimethylpropyl)(chlorocarbonyl)amino)methyl)-4-fluoropyrrolidine-1-carboxylate 
• 1338780-12-3 C₃₃H₃₄F₃N₅O₂ 
• 1338780-11-2 (3R,4R)-benzyl 3-(((R)-1-(3-(2,5-difluorophenyl)-1-(3-fluorobenzyl)-1H-1,2,4-triazol-5-yl)-2,2-dimethylpropylamino)methyl)-4-fluoropyrrolidine-1-carboxylate 
• 1338780-09-8 (R)-tert-butyl 1-(5-(2,5-difluorophenyl)-1-(3-fluorobenzyl)-1H-1,2,4-triazol-3-yl)-2,2-dimethylpropylcarbamate 
• 1338780-08-7 (R)-tert-butyl 1-(3-(2,5-difluorophenyl)-1-(3-fluorobenzyl)-1H-1,2,4-triazol-5-yl)-2,2-dimethylpropylcarbamate 
• 1338780-07-6 (3S,4R)-benzyl 3-((((R)-1-(1-benzyl-3-(2,5-difluorophenyl)-1H-1,2,4-triazol-5-yl)-2,2-dimethylpropyl)(chlorocarbonyl)amino)methyl)-4-fluoropyrrolidine-1-carboxylate 
• 1338780-06-5 (3R,4R)-benzyl 3-(((S)-N-((R)-1-(1-benzyl-3-(2,5-difluorophenyl)-1H-1,2,4-triazol-5-yl)-2,2-dimethylpropyl)tetrahydrofuran-2-carboxamido)methyl)-4-fluoropyrrolidine-1-carboxylate 
• 1338780-05-4 C₃₃H₃₅F₂N₅O₂ 
• 1338780-04-3 (3R,4R)-benzyl 3-(((R)-1-(1-benzyl-3-(2,5-difluorophenyl)-1H-1,2,4-triazol-5-yl)-2,2-dimethylpropylamino)methyl)-4-fluoropyrrolidine-1-carboxylate 
• 1338779-93-3 (S)-N-((R)-1-(3-(2,5-difluorophenyl)-1-(3-fluorobenzyl)-1H-1,2,4-triazol-5-yl)-2,2-dimethylpropyl)-N-(((3S,4R)-4-fluoropyrrolidin-3-yl)methyl)-2-hydroxypropanamide 

Relevant academic research and scientific papers

TRIAZOLE COMPOUNDS AS KSP INHIBITORS

The present invention provides triazole compounds of Formula I: as further described herein. The invention also provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of Formula I, and a method of treating a diso

SUBSTITUTED PYRAZOLE AND TRIAZOLE COMPOUNDS AS KSP INHIBITORS

Disclosed are new substituted pyrazole and triazole compounds of Formula (I) and pharmaceutically acceptable salts, esters or prodrugs thereof, compositions of the derivatives together with pharmaceutically acceptable carriers, and uses thereof